XML 19 R7.htm IDEA: XBRL DOCUMENT v3.25.0.1
CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($)
shares in Thousands, $ in Thousands
Total
Common Stock
Additional Paid-in Capital
Treasury Stock
Accumulated Other Comprehensive (Loss) Income
Accumulated Deficit
Beginning balance (in shares) at Dec. 31, 2021   108,929        
Beginning balance at Dec. 31, 2021 $ 215,313 $ 1,089 $ 869,059 $ 0 $ (306) $ (654,529)
Increase (Decrease) in Stockholders' Deficit [Roll Forward]            
Exercise of stock options (in shares) 1,174 1,174        
Exercise of stock options $ 11,721 $ 12 11,709      
Vesting of restricted stock units (in shares)   2,510        
Vesting of restricted stock units 0 $ 25 (25)      
Issuance of common stock under employee stock purchase plan (in shares)   443        
Issuance of common stock under employee stock purchase plan 14,791 $ 5 14,786      
Stock-based compensation 122,308   122,308      
Other comprehensive income (loss) (1,045)       (1,045)  
Net loss (92,222)         (92,222)
Ending balance (in shares) at Dec. 31, 2022   113,056        
Ending balance at Dec. 31, 2022 $ 270,866 $ 1,131 1,017,837 0 (1,351) (746,751)
Increase (Decrease) in Stockholders' Deficit [Roll Forward]            
Exercise of stock options (in shares) 387 387        
Exercise of stock options $ 3,501 $ 4 3,497      
Vesting of restricted stock units (in shares)   3,153        
Vesting of restricted stock units 0 $ 32 (32)      
Vesting of performance stock units (in shares)   91        
Vesting of performance stock units 0          
Issuance of restricted stock award (in shares)   311        
Issuance of restricted stock awards 0 $ 3 (3)      
Issuance of common stock under employee stock purchase plan (in shares)   506        
Issuance of common stock under employee stock purchase plan 16,224 $ 5 16,219      
Purchase of treasury stock (14,934)     (14,934)    
Fair value of replacement equity attributable to pre-acquisition service 526   526      
Stock-based compensation 147,056   147,056      
Other comprehensive income (loss) 1,389       1,389  
Net loss $ (78,284)         (78,284)
Ending balance (in shares) at Dec. 31, 2023 117,504 117,504        
Ending balance at Dec. 31, 2023 $ 346,344 $ 1,175 1,185,100 (14,934) 38 (825,035)
Increase (Decrease) in Stockholders' Deficit [Roll Forward]            
Exercise of stock options (in shares) 1,044 1,044        
Exercise of stock options $ 8,064 $ 11 8,053      
Vesting of restricted stock units (in shares)   3,217        
Vesting of restricted stock units 0 $ 32 (32)      
Vesting of performance stock units (in shares)   107        
Vesting of performance stock units 0 $ 1 (1)      
Issuance of common stock under employee stock purchase plan (in shares)   499        
Issuance of common stock under employee stock purchase plan 16,262 $ 5 16,257      
Purchase of treasury stock (99,977)     (99,977)    
Fair value of replacement equity attributable to pre-acquisition service 42   42      
Stock-based compensation 165,240   165,240      
Other comprehensive income (loss) 280       280  
Net loss $ (36,301)         (36,301)
Ending balance (in shares) at Dec. 31, 2024 122,371 122,371        
Ending balance at Dec. 31, 2024 $ 399,954 $ 1,224 $ 1,374,659 $ (114,911) $ 318 $ (861,336)